Watchlist Price Alert

AbCellera Biologics Inc. (ABCL)

NASDAQ: ABCL · Real-Time Price · USD

3.25

0.09 (2.85%)

At close: Jun 17, 2025, 10:53 AM

AbCellera Biologics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	156.32M	133.32M	386.54M	476.14M	594.12M	7.55M	10.44M
Short-Term Investments	469.29M	627.26M	499.95M	246.84M	n/a	n/a	n/a
Long-Term Investments	82.3M	65.94M	72.52M	50.31M	19.25M	n/a	n/a
Other Long-Term Assets	96.54M	94.24M	41.03M	23.23M	2.49M	2.37M	n/a
Receivables	92.13M	64.38M	38.59M	160.58M	213.24M	2.12M	1.4M
Inventory	n/a	1.11M	1.53M	1.67M	1.41M	163K	n/a
Other Current Assets	33.63M	45.91M	89.82M	39.28M	489K	2.25M	n/a
Total Current Assets	751.37M	871.99M	1.03B	929.8M	813.33M	12.64M	15.16M
Property-Plant & Equipment	340.43M	287.7M	217.25M	111.62M	17.92M	8.48M	6.33M
Goodwill & Intangibles	89.92M	168.23M	179.31M	196.2M	146.65M	n/a	n/a
Total Long-Term Assets	609.18M	616.11M	515.42M	388.77M	192.21M	10.85M	6.33M
Total Assets	1.36B	1.49B	1.54B	1.32B	1.01B	23.49M	21.49M
Account Payables	34.35M	25.51M	14.83M	14.92M	7.32M	1.64M	1.52M
Deferred Revenue	13.52M	18.96M	21.61M	7.54M	6.59M	3.24M	2.33M
Short-Term Debt	n/a	n/a	n/a	n/a	190K	2.47M	2.53M
Other Current Liabilities	28.74M	60.68M	69.84M	54.85M	50.77M	3.36M	50.12K
Total Current Liabilities	76.61M	119.01M	118.32M	120.68M	103.49M	7.89M	6.43M
Long-Term Debt	n/a	n/a	n/a	n/a	2.2M	1.36M	911.22K
Other Long-Term Liabilities	62.21M	10.82M	19.14M	37.62M	13.57M	-138	277.13K
Total Long-Term Liabilities	227.86M	216.76M	189.31M	172.16M	71.54M	5.34M	3.45M
Total Liabilities	304.47M	335.78M	307.63M	292.84M	175.03M	13.24M	9.88M
Total Debt	65.36M	77.38M	82.26M	36.41M	6.1M	6.89M	3.44M
Common Stock	777.17M	753.2M	734.37M	722.43M	710.39M	5.12M	5.07M
Retained Earnings	116.93M	279.79M	426.19M	267.67M	114.2M	-4.72M	-2.5M
Comprehensive Income	-4.38M	-1.72M	-1.39M	280K	0.00	0.00	-1.55M
Shareholders Equity	1.06B	1.15B	1.23B	1.03B	830.51M	10.25M	11.61M
Total Investments	551.59M	693.2M	572.47M	297.15M	19.25M	n/a	n/a